New 3-D visual of intestinal growth promoting peptide

Feb 03, 2011

UCD Conway researchers have determined the 3-dimensional solution structure of glucagon-like peptide-2 (GLP-2) for the first time using nuclear magnetic resonance and molecular modelling. This visual was selected as the cover image of the current issue of the biochemical journal, FEBS Letters.

Glucagon-like peptide-2 (GLP-2) is a therapeutic target used in the treatment of short bowel syndrome, where nutrients are not being correctly absorbed either due to severe intestinal disease or surgical resection of a large portion of the intestine.

Acting as an intestinal growth promoting agent in the small and large bowel, GLP-2 promotes the expansion of the epithelial mucosa and, consequently, better absorption of nutrients. It does this by stimulating crypt and preventing in the gut epithelium.

Conway Fellow, Dr Chandralal Hewage led the study to determine the structure of the peptide and the nature of the docking interaction between the hormone and its receptor. Commenting on the research, Dr Hewage said, “These results provide a valuable insight into the structural and functional properties of GLP-2 and its receptor interactions, which could help in the design of novel therapeutic drugs that may be active at the GLP-2 receptor”.

PhD student, Kalyana Venneti won the young researcher award for his presentation of this work at the 18th International Symposium on Regulatory held in Belfast from September 5th – 8th 2010. Science Foundation Ireland funded the study through research and studentship grants.

Explore further: Researchers identify the metabolic products of foulbrood pathogen in honeybees

More information: Conformational and molecular interaction studies of glucagon-like peptide-2 with its N-terminal extracellular receptor domain. Kalyana C. Venneti, Chandralal Hewage. FEBS Letters volume 585 issue 2 21 January 2011

Provided by University College Dublin

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Your gut has taste receptors

Aug 20, 2007

Researchers in the Department of Neuroscience at Mount Sinai School of Medicine have identified taste receptors in the human intestines. The taste receptor T1R3 and the taste G protein gustducin are critical to sweet taste ...

A new molecule to combat diabetes and obesity

Sep 01, 2009

Type 2 diabetes, the most common form of diabetes, is increasing at an alarming state with more than 180 million people affected worldwide. With the rising incidence of obesity, a major risk factor for the onset of type 2 ...

Key regulator in inflammatory bowel disease identified

Aug 09, 2010

UCD Conway scientists led by Professor Cormac Taylor have pinpointed a key regulator involved in maintaining the functional integrity of the gut lining as part of their reseach into inflammatory bowel disease (IBD). Together ...

Natural fibre may take extra pounds away

Jan 31, 2007

It sounds almost too good to be true, but Dr. Raylene Reimer, a researcher at the University of Calgary, Faculty of Kinesiology, believes she may have found an important weapon in the war against obesity.

Recommended for you

Scientists develop pioneering new spray-on solar cells

10 hours ago

(Phys.org) —A team of scientists at the University of Sheffield are the first to fabricate perovskite solar cells using a spray-painting process – a discovery that could help cut the cost of solar electricity.

User comments : 0